AMJEVITA
NDC 72511-479, adalimumab-atto, injection, from Amgen USA Inc..
- Product NDC
- 72511-479
- Status
- Listed
- Labeler
- Amgen USA Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761024
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72511-479 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ADALIMUMAB40 mg/.4mL
Pharmacologic classes
Antibodies, Monoclonal [CS]; Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72511-479-02 | 72511047902 | 2 SYRINGE in 1 CARTON (72511-479-02) / .4 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b7178e36-6787-45ab-8fee-be59bc6a4aa4
Use it
Look up 72511-479 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72511-479 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72511-479. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.